Skip to main content

Von Willebrand Disease clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • ATHN 9: Severe VWD Natural History Study

    open to all eligible people

    ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participants with clinically severe congenital VWD.

    at UCSD

  • Minimize Menorrhagia in Women With Von Willebrand Disease

    open to eligible females ages 13-45

    This is an outpatient, 24-week Phase III prospective, randomized, crossover trial comparing recombinant von Willebrand factor (rVWF) and tranexamic acid (TA, Lysteda®) to minimize menorrhagia in women with von Willebrand disease (VWD). The purpose of this Phase III multicenter prospective, randomized, crossover arm trial is to compare recombinant von Willebrand factor (rVWF) to tranexamic acid (TA) in reducing the severity of menorrhagia in women with von Willebrand disease.

    at UCSF

Last updated: